Gammavision Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 0.70 M
- Paid Up Capital ₹ 0.60 M
- Company Age 22 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 3.38 Cr
- Revenue Growth 5.59%
- Profit Growth 5.49%
- Ebitda 9.23%
- Net Worth 59.28%
- Total Assets 10.96%
About Gammavision Diagnostics
Gammavision Diagnostics Private Limited (GDPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 November 2002 and has a history of 22 years and two months. Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.70 M and a paid-up capital of Rs 0.60 M.
The company has closed loans amounting to ₹3.38 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Jeetal Sancheti, Madhav Kulkarni, Vijay Kadam, and Eight other members serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85110PN2002PTC017458
-
Company No.
017458
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Nov 2002
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Gammavision Diagnostics?
Board Members (11)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Jeetal Sancheti | Director | 01-Oct-2007 | Current |
Madhav Kulkarni | Director | 13-Jan-2003 | Current |
Vijay Kadam | Director | 13-Jan-2003 | Current |
Ratishchandran Nair | Director | 14-Jan-2003 | Current |
Shrikant Gundawar | Director | 13-Jan-2003 | Current |
Kedar Bhate | Director | 28-Nov-2002 | Current |
Financial Performance of Gammavision Diagnostics.
Gammavision Diagnostics Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 5.59% increase. The company also saw a slight improvement in profitability, with a 5.49% increase in profit. The company's net worth Soared by an impressive increase of 59.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Gammavision Diagnostics?
In 2020, Gammavision Diagnostics had a promoter holding of 8.33% and a public holding of 91.67%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹33.80 M
Charges Breakdown by Lending Institutions
- Siemens Financial Services Private Limited : 1.39 Cr
- Shree Sharada Sahakari Bank Ltd. : 0.70 Cr
- Shree Sharada Sahakari Bank Limited. : 0.69 Cr
- Shree Sharda Sahakari Bank Ltd. : 0.60 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
18 Sep 2015 | Siemens Financial Services Private Limited | ₹1.39 Cr | Satisfied |
16 Mar 2013 | Shree Sharada Sahakari Bank Limited. | ₹6.90 M | Satisfied |
29 Jul 2008 | Shree Sharada Sahakari Bank Ltd. | ₹7.00 M | Satisfied |
18 Jan 2003 | Shree Sharda Sahakari Bank Ltd. | ₹6.00 M | Satisfied |
How Many Employees Work at Gammavision Diagnostics?
Unlock and access historical data on people associated with Gammavision Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gammavision Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gammavision Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.